| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosome binding | 1.33e-05 | 98 | 62 | 5 | GO:0031491 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 2.77e-05 | 114 | 62 | 5 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 4.15e-05 | 124 | 62 | 5 | GO:0101005 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 6.68e-05 | 137 | 62 | 5 | GO:0019783 | |
| GeneOntologyMolecularFunction | phosphatidic acid transfer activity | 1.97e-04 | 7 | 62 | 2 | GO:1990050 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 3.24e-04 | 192 | 62 | 5 | GO:0008234 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 3.16e-05 | 125 | 60 | 5 | GO:0016579 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 3.46e-05 | 22 | 60 | 3 | GO:0006337 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 4.53e-05 | 24 | 60 | 3 | GO:0032986 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 6.20e-05 | 144 | 60 | 5 | GO:0070646 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 8.10e-05 | 29 | 60 | 3 | GO:2000819 | |
| GeneOntologyCellularComponent | npBAF complex | 8.00e-06 | 14 | 60 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 8.00e-06 | 14 | 60 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 1.23e-05 | 16 | 60 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 8.64e-05 | 30 | 60 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.67e-04 | 96 | 60 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.54e-04 | 107 | 60 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | bBAF complex | 3.59e-04 | 10 | 60 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | ATPase complex | 5.17e-04 | 129 | 60 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 ARID1B SUGP1 SMARCC1 CHD4 SSRP1 ARID1A MIDEAS RBM47 CWC22 HNRNPH1 | 1.68e-03 | 1377 | 60 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 2.15e-03 | 24 | 60 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.42e-03 | 477 | 60 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | chromatin | SOX3 NCOA2 TFEB ARID1B SMARCC1 TNKS1BP1 CHD4 PAX7 SSRP1 FOXA1 ARID1A | 2.96e-03 | 1480 | 60 | 11 | GO:0000785 |
| Domain | HABP4_PAI-RBP1 | 1.34e-09 | 16 | 61 | 5 | PF04774 | |
| Domain | HABP4_PAIRBP1-bd | 1.34e-09 | 16 | 61 | 5 | IPR006861 | |
| Domain | USP_CS | 2.41e-06 | 66 | 61 | 5 | IPR018200 | |
| Domain | USP_1 | 3.23e-06 | 70 | 61 | 5 | PS00972 | |
| Domain | UCH | 3.47e-06 | 71 | 61 | 5 | PF00443 | |
| Domain | USP_2 | 3.47e-06 | 71 | 61 | 5 | PS00973 | |
| Domain | USP_3 | 3.72e-06 | 72 | 61 | 5 | PS50235 | |
| Domain | USP_dom | 3.72e-06 | 72 | 61 | 5 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 3.72e-06 | 72 | 61 | 5 | IPR001394 | |
| Domain | BAF250_C | 1.05e-05 | 2 | 61 | 2 | IPR033388 | |
| Domain | BAF250_C | 1.05e-05 | 2 | 61 | 2 | PF12031 | |
| Domain | BAF250/Osa | 1.05e-05 | 2 | 61 | 2 | IPR021906 | |
| Domain | zf-RNPHF | 3.14e-05 | 3 | 61 | 2 | PF08080 | |
| Domain | Znf_CHHC | 3.14e-05 | 3 | 61 | 2 | IPR012996 | |
| Domain | HMG_box_dom | 6.01e-05 | 65 | 61 | 4 | IPR009071 | |
| Domain | PRELI_MSF1 | 1.56e-04 | 6 | 61 | 2 | PS50904 | |
| Domain | PRELI | 1.56e-04 | 6 | 61 | 2 | PF04707 | |
| Domain | PRELI/MSF1_dom | 1.56e-04 | 6 | 61 | 2 | IPR006797 | |
| Domain | VHS | 3.72e-04 | 9 | 61 | 2 | PF00790 | |
| Domain | VHS | 3.72e-04 | 9 | 61 | 2 | PS50179 | |
| Domain | VHS | 3.72e-04 | 9 | 61 | 2 | SM00288 | |
| Domain | VHS_dom | 3.72e-04 | 9 | 61 | 2 | IPR002014 | |
| Domain | HMG_box | 6.91e-04 | 53 | 61 | 3 | PF00505 | |
| Domain | HMG_BOX_2 | 7.30e-04 | 54 | 61 | 3 | PS50118 | |
| Domain | HMG | 7.30e-04 | 54 | 61 | 3 | SM00398 | |
| Domain | - | 7.71e-04 | 55 | 61 | 3 | 1.10.30.10 | |
| Domain | - | 1.07e-03 | 15 | 61 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.07e-03 | 15 | 61 | 2 | SM00501 | |
| Domain | ARID_dom | 1.07e-03 | 15 | 61 | 2 | IPR001606 | |
| Domain | ARID | 1.07e-03 | 15 | 61 | 2 | PS51011 | |
| Domain | ARID | 1.07e-03 | 15 | 61 | 2 | PF01388 | |
| Domain | - | 3.24e-03 | 26 | 61 | 2 | 1.25.40.90 | |
| Domain | SANT_dom | 3.24e-03 | 26 | 61 | 2 | IPR017884 | |
| Domain | SANT | 3.76e-03 | 28 | 61 | 2 | PS51293 | |
| Domain | ENTH_VHS | 4.02e-03 | 29 | 61 | 2 | IPR008942 | |
| Domain | RRM_1 | 4.75e-03 | 208 | 61 | 4 | PF00076 | |
| Domain | Chromo/shadow_dom | 5.19e-03 | 33 | 61 | 2 | IPR000953 | |
| Domain | CHROMO | 5.19e-03 | 33 | 61 | 2 | SM00298 | |
| Domain | RRM | 5.52e-03 | 217 | 61 | 4 | SM00360 | |
| Domain | Myb_DNA-binding | 5.83e-03 | 35 | 61 | 2 | PF00249 | |
| Domain | RRM_dom | 6.45e-03 | 227 | 61 | 4 | IPR000504 | |
| Pathway | REACTOME_RAS_PROCESSING | 1.59e-05 | 45 | 48 | 4 | MM15671 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 9.82e-05 | 221 | 48 | 6 | M27578 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.27e-04 | 29 | 48 | 3 | M48076 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.56e-04 | 31 | 48 | 3 | M39522 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.25e-04 | 35 | 48 | 3 | M47969 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.65e-04 | 37 | 48 | 3 | M27797 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 3.25e-04 | 97 | 48 | 4 | M48262 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.87e-04 | 42 | 48 | 3 | M48237 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 4.63e-04 | 191 | 48 | 5 | MM15289 | |
| Pathway | WP_THERMOGENESIS | 4.89e-04 | 108 | 48 | 4 | M39746 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 5.02e-04 | 10 | 48 | 2 | MM1532 | |
| Pathway | REACTOME_DEUBIQUITINATION | 5.02e-04 | 299 | 48 | 6 | M27574 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 5.24e-04 | 110 | 48 | 4 | M48043 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 7.33e-04 | 12 | 48 | 2 | M22006 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.19e-03 | 137 | 48 | 4 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.36e-03 | 142 | 48 | 4 | M48257 | |
| Pathway | WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION | 1.49e-03 | 17 | 48 | 2 | M39907 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 1.68e-03 | 18 | 48 | 2 | M39737 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | NCOA2 ZNF462 ARID1B SMARCC1 CHD4 SSRP1 FOXA1 ARID1A MIDEAS HNRNPH2 | 6.74e-12 | 220 | 62 | 10 | 35785414 |
| Pubmed | NCOA2 ARID1B SUGP1 SMARCC1 SSBP2 CHD4 FOXA1 ARID1A MIDEAS PRRC2B | 4.72e-11 | 268 | 62 | 10 | 33640491 | |
| Pubmed | 3.49e-09 | 33 | 62 | 5 | 20228807 | ||
| Pubmed | 4.08e-09 | 34 | 62 | 5 | 20403174 | ||
| Pubmed | 4.08e-09 | 34 | 62 | 5 | 17109758 | ||
| Pubmed | 4.08e-09 | 34 | 62 | 5 | 20388806 | ||
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | 4.08e-09 | 34 | 62 | 5 | 14699124 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | 4.08e-09 | 34 | 62 | 5 | 20715989 | |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | 4.08e-09 | 34 | 62 | 5 | 9806828 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | 4.08e-09 | 34 | 62 | 5 | 20368735 | |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | 4.08e-09 | 34 | 62 | 5 | 15780755 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | 4.08e-09 | 34 | 62 | 5 | 19188362 | |
| Pubmed | 4.08e-09 | 34 | 62 | 5 | 11941478 | ||
| Pubmed | 4.08e-09 | 34 | 62 | 5 | 10936051 | ||
| Pubmed | 4.08e-09 | 34 | 62 | 5 | 21448158 | ||
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | 4.76e-09 | 35 | 62 | 5 | 16611142 | |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | 4.76e-09 | 35 | 62 | 5 | 21239494 | |
| Pubmed | 5.52e-09 | 36 | 62 | 5 | 20147298 | ||
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | 6.37e-09 | 37 | 62 | 5 | 20228808 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 9.58e-09 | 40 | 62 | 5 | 34585037 | |
| Pubmed | TANC2 NCOA2 ZNF462 MAGI1 GPRASP1 CELSR2 ATXN2 FAM120C SMARCC1 ELAVL4 CHD4 BSN PRRC2B | 1.23e-08 | 963 | 62 | 13 | 28671696 | |
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 2.16e-08 | 4 | 62 | 3 | 15170388 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | 5.35e-08 | 21 | 62 | 4 | 8622927 | |
| Pubmed | 5.35e-08 | 21 | 62 | 4 | 14583620 | ||
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | 5.35e-08 | 21 | 62 | 4 | 11468161 | |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | 5.35e-08 | 21 | 62 | 4 | 8756639 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | 5.35e-08 | 21 | 62 | 4 | 12447969 | |
| Pubmed | 5.35e-08 | 21 | 62 | 4 | 18980247 | ||
| Pubmed | 6.54e-08 | 22 | 62 | 4 | 9154835 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ARID1B SMARCC1 YTHDC2 CHD4 SSRP1 ARID1A HNRNPH1 HNRNPH2 MAP3K4 | 8.58e-08 | 440 | 62 | 9 | 34244565 |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | 9.47e-08 | 24 | 62 | 4 | 8995226 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 16230384 | ||
| Pubmed | 1.13e-07 | 25 | 62 | 4 | 21115691 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.18e-07 | 457 | 62 | 9 | 32344865 | |
| Pubmed | 1.33e-07 | 26 | 62 | 4 | 35816173 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 23540691 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.09e-07 | 351 | 62 | 8 | 38297188 | |
| Pubmed | 2.10e-07 | 29 | 62 | 4 | 36800290 | ||
| Pubmed | 2.10e-07 | 29 | 62 | 4 | 32527007 | ||
| Pubmed | 3.29e-07 | 251 | 62 | 7 | 31076518 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF462 ARID1B SUGP1 SMARCC1 TNKS1BP1 SSBP2 CHD4 SSRP1 ARID1A CWC22 HNRNPH1 HNRNPH2 | 3.98e-07 | 1082 | 62 | 12 | 38697112 |
| Pubmed | 3.98e-07 | 83 | 62 | 5 | 28794006 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 4.50e-07 | 9 | 62 | 3 | 20086098 | |
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 37805104 | ||
| Pubmed | 5.78e-07 | 37 | 62 | 4 | 24335282 | ||
| Pubmed | 6.42e-07 | 10 | 62 | 3 | 12665591 | ||
| Pubmed | NCOA2 ZNF462 ARID1B ATXN2 HGS SUGP1 SMARCC1 SSBP2 PAX7 FOXA1 ARID1A MIDEAS PRRC2B | 1.14e-06 | 1429 | 62 | 13 | 35140242 | |
| Pubmed | 1.17e-06 | 103 | 62 | 5 | 32744500 | ||
| Pubmed | 1.17e-06 | 12 | 62 | 3 | 11734557 | ||
| Pubmed | ARID1B ATXN2 SMARCC1 YTHDC2 SSRP1 ARID1A MIDEAS HNRNPH1 PRRC2B | 1.40e-06 | 615 | 62 | 9 | 31048545 | |
| Pubmed | 1.52e-06 | 13 | 62 | 3 | 17340523 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ATXN2 FAM120C SUGP1 YTHDC2 APOBEC3C SSRP1 RBM47 HNRNPH1 HNRNPH2 PRRC2B | 1.55e-06 | 807 | 62 | 10 | 22681889 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.72e-06 | 203 | 62 | 6 | 22083510 | |
| Pubmed | 1.90e-06 | 638 | 62 | 9 | 31182584 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.98e-06 | 50 | 62 | 4 | 31806660 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 2.42e-06 | 15 | 62 | 3 | 17255939 | |
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 23785148 | ||
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 11263494 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 2.42e-06 | 15 | 62 | 3 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 2.42e-06 | 15 | 62 | 3 | 17920018 | |
| Pubmed | Hrs regulates the endocytic sorting of the fibroblast growth factor receptor 2b. | 3.13e-06 | 2 | 62 | 2 | 19362549 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 34386776 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23202128 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 33890484 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 3.13e-06 | 2 | 62 | 2 | 24562383 | |
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 3.13e-06 | 2 | 62 | 2 | 37611161 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 32791957 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 3.13e-06 | 2 | 62 | 2 | 29890703 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24788099 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 3.13e-06 | 2 | 62 | 2 | 28967863 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 33052929 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 3.13e-06 | 2 | 62 | 2 | 27562491 | |
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 3.60e-06 | 17 | 62 | 3 | 12368262 | |
| Pubmed | 3.60e-06 | 17 | 62 | 3 | 11078522 | ||
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 4.32e-06 | 18 | 62 | 3 | 28068325 | |
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 4.32e-06 | 18 | 62 | 3 | 23698369 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 4.34e-06 | 370 | 62 | 7 | 22922362 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 4.43e-06 | 135 | 62 | 5 | 31077711 | |
| Pubmed | 5.12e-06 | 19 | 62 | 3 | 16932743 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 5.12e-06 | 19 | 62 | 3 | 12110891 | |
| Pubmed | SUGP1 ELAVL4 APOBEC3C SSRP1 RBM47 CWC22 HNRNPH1 HNRNPH2 PRRC2B | 5.24e-06 | 723 | 62 | 9 | 34133714 | |
| Pubmed | 5.86e-06 | 549 | 62 | 8 | 38280479 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 6.50e-06 | 146 | 62 | 5 | 23892456 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ARID1B ATXN2 SUGP1 SMARCC1 CHD4 SSRP1 ARID1A MIDEAS CWC22 HNRNPH1 | 6.80e-06 | 954 | 62 | 10 | 36373674 |
| Pubmed | Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. | 8.11e-06 | 22 | 62 | 3 | 18377426 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 8.60e-06 | 411 | 62 | 7 | 35182466 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 9.03e-06 | 271 | 62 | 6 | 32433965 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 9.07e-06 | 583 | 62 | 8 | 29844126 | |
| Pubmed | 9.25e-06 | 157 | 62 | 5 | 30186101 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 9.31e-06 | 23 | 62 | 3 | 30962207 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 9.31e-06 | 23 | 62 | 3 | 8804307 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 33432679 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 21647563 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 9.37e-06 | 3 | 62 | 2 | 26716708 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 36931659 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 10456323 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 9.37e-06 | 3 | 62 | 2 | 22426308 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 24382590 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 14980514 | ||
| Interaction | EGR2 interactions | 3.50e-08 | 171 | 59 | 8 | int:EGR2 | |
| Interaction | CRX interactions | 5.05e-08 | 254 | 59 | 9 | int:CRX | |
| Interaction | AR interactions | NCOA2 ZNF462 ARID1B SUGP1 SMARCC1 SSBP2 CHD4 ITPRID2 SSRP1 FOXA1 ARID1A MIDEAS HNRNPH1 HNRNPH2 PRRC2B | 1.13e-07 | 992 | 59 | 15 | int:AR |
| Interaction | MYCN interactions | ARID1B ATXN2 FAM120C SUGP1 SMARCC1 ELAVL4 YTHDC2 CHD4 APOBEC3C SSRP1 ARID1A MIDEAS CWC22 SPTY2D1 HNRNPH1 HNRNPH2 PRRC2B | 2.38e-07 | 1373 | 59 | 17 | int:MYCN |
| Interaction | SS18L1 interactions | 4.14e-07 | 98 | 59 | 6 | int:SS18L1 | |
| Interaction | TLX1 interactions | 7.70e-07 | 175 | 59 | 7 | int:TLX1 | |
| Interaction | ESRRB interactions | 9.17e-07 | 262 | 59 | 8 | int:ESRRB | |
| Interaction | ALG13 interactions | 1.04e-06 | 183 | 59 | 7 | int:ALG13 | |
| Interaction | TBXT interactions | 1.12e-06 | 116 | 59 | 6 | int:TBXT | |
| Interaction | HNF1B interactions | 1.34e-06 | 190 | 59 | 7 | int:HNF1B | |
| Interaction | GCM1 interactions | 1.64e-06 | 68 | 59 | 5 | int:GCM1 | |
| Interaction | SNRNP40 interactions | NPC1 ZNF462 ARID1B SUGP1 SMARCC1 SSRP1 ARID1A MIDEAS CWC22 SPTY2D1 HNRNPH1 | 2.03e-06 | 637 | 59 | 11 | int:SNRNP40 |
| Interaction | SOX2 interactions | SOX3 NCOA2 ZNF462 TFEB COL8A1 ARID1B SMARCC1 YTHDC2 CHD4 ITPRID2 SSRP1 ARID1A MIDEAS HNRNPH1 HNRNPH2 PRRC2B | 2.09e-06 | 1422 | 59 | 16 | int:SOX2 |
| Interaction | RBMS1 interactions | 2.36e-06 | 207 | 59 | 7 | int:RBMS1 | |
| Interaction | HSFY1 interactions | 2.88e-06 | 34 | 59 | 4 | int:HSFY1 | |
| Interaction | SNIP1 interactions | 3.21e-06 | 417 | 59 | 9 | int:SNIP1 | |
| Interaction | PHF10 interactions | 3.22e-06 | 139 | 59 | 6 | int:PHF10 | |
| Interaction | ERG interactions | 3.87e-06 | 223 | 59 | 7 | int:ERG | |
| Interaction | NFIX interactions | 4.35e-06 | 227 | 59 | 7 | int:NFIX | |
| Interaction | POU5F1 interactions | ZNF462 TFEB ARID1B SUGP1 SMARCC1 CHD4 SSRP1 ARID1A TOX2 PRRC2B | 6.76e-06 | 584 | 59 | 10 | int:POU5F1 |
| Interaction | SMARCA2 interactions | 7.20e-06 | 346 | 59 | 8 | int:SMARCA2 | |
| Interaction | TFCP2L1 interactions | 1.05e-05 | 99 | 59 | 5 | int:TFCP2L1 | |
| Interaction | PAX6 interactions | 1.08e-05 | 366 | 59 | 8 | int:PAX6 | |
| Interaction | SIRT6 interactions | ARID1B CELSR2 SMARCC1 YTHDC2 CHD4 SSRP1 ARID1A HNRNPH1 HNRNPH2 MAP3K4 | 1.27e-05 | 628 | 59 | 10 | int:SIRT6 |
| Interaction | TLE3 interactions | 1.32e-05 | 376 | 59 | 8 | int:TLE3 | |
| Interaction | SMARCD3 interactions | 1.53e-05 | 107 | 59 | 5 | int:SMARCD3 | |
| Interaction | GATA3 interactions | 1.76e-05 | 187 | 59 | 6 | int:GATA3 | |
| Interaction | NFIA interactions | 1.82e-05 | 188 | 59 | 6 | int:NFIA | |
| Interaction | PAX8 interactions | 1.83e-05 | 111 | 59 | 5 | int:PAX8 | |
| Interaction | SMAP2 interactions | 1.87e-05 | 189 | 59 | 6 | int:SMAP2 | |
| Interaction | MYOD1 interactions | 2.17e-05 | 194 | 59 | 6 | int:MYOD1 | |
| Interaction | TPRX2 interactions | 2.17e-05 | 56 | 59 | 4 | int:TPRX2 | |
| Interaction | RC3H1 interactions | ATXN2 FAM120C SMARCC1 YTHDC2 TNKS1BP1 RBM47 SPTY2D1 HNRNPH1 HNRNPH2 PRRC2B | 2.43e-05 | 677 | 59 | 10 | int:RC3H1 |
| Interaction | FUBP3 interactions | 2.49e-05 | 297 | 59 | 7 | int:FUBP3 | |
| Interaction | GATA4 interactions | 2.50e-05 | 411 | 59 | 8 | int:GATA4 | |
| Interaction | GATA2 interactions | 2.51e-05 | 199 | 59 | 6 | int:GATA2 | |
| Interaction | TEX13B interactions | 2.62e-05 | 20 | 59 | 3 | int:TEX13B | |
| Interaction | FEV interactions | 2.80e-05 | 203 | 59 | 6 | int:FEV | |
| Interaction | SP7 interactions | 2.89e-05 | 304 | 59 | 7 | int:SP7 | |
| Interaction | NUP35 interactions | 3.12e-05 | 424 | 59 | 8 | int:NUP35 | |
| Interaction | FLI1 interactions | 3.26e-05 | 62 | 59 | 4 | int:FLI1 | |
| Interaction | NFIC interactions | 3.39e-05 | 210 | 59 | 6 | int:NFIC | |
| Interaction | ATXN1 interactions | SOX3 GGA2 ADSL ATXN2 SUGP1 ELAVL4 CHD4 PAX7 ARID1A HNRNPH1 HNRNPH2 PRRC2B | 3.91e-05 | 1039 | 59 | 12 | int:ATXN1 |
| Interaction | INPP5E interactions | 3.93e-05 | 65 | 59 | 4 | int:INPP5E | |
| Interaction | SMG7 interactions | 3.93e-05 | 319 | 59 | 7 | int:SMG7 | |
| Interaction | SYNCRIP interactions | ATXN2 FAM120C ELAVL4 YTHDC2 CHD4 SSRP1 HNRNPH1 HNRNPH2 PRRC2B MAP3K4 | 4.15e-05 | 721 | 59 | 10 | int:SYNCRIP |
| Interaction | RBM19 interactions | 4.51e-05 | 221 | 59 | 6 | int:RBM19 | |
| Interaction | NFIB interactions | 5.97e-05 | 142 | 59 | 5 | int:NFIB | |
| Interaction | NANOG interactions | 7.57e-05 | 481 | 59 | 8 | int:NANOG | |
| Interaction | ADARB1 interactions | 8.49e-05 | 489 | 59 | 8 | int:ADARB1 | |
| Interaction | HNRNPC interactions | 8.79e-05 | 634 | 59 | 9 | int:HNRNPC | |
| Interaction | SOX7 interactions | 9.77e-05 | 82 | 59 | 4 | int:SOX7 | |
| Interaction | STK11IP interactions | 1.02e-04 | 83 | 59 | 4 | int:STK11IP | |
| Interaction | YLPM1 interactions | 1.05e-04 | 160 | 59 | 5 | int:YLPM1 | |
| Interaction | R3HDM1 interactions | 1.07e-04 | 84 | 59 | 4 | int:R3HDM1 | |
| Interaction | LSM14A interactions | 1.11e-04 | 260 | 59 | 6 | int:LSM14A | |
| Interaction | IRF4 interactions | 1.12e-04 | 85 | 59 | 4 | int:IRF4 | |
| Interaction | KIRREL3 interactions | 1.25e-04 | 6 | 59 | 2 | int:KIRREL3 | |
| Interaction | SS18 interactions | 1.29e-04 | 88 | 59 | 4 | int:SS18 | |
| Interaction | RC3H2 interactions | ATXN2 FAM120C SMARCC1 YTHDC2 TNKS1BP1 RBM47 HNRNPH1 HNRNPH2 PRRC2B | 1.29e-04 | 667 | 59 | 9 | int:RC3H2 |
| Interaction | CIC interactions | 1.38e-04 | 673 | 59 | 9 | int:CIC | |
| Interaction | WWP2 interactions | ARID1B ATXN2 HGS SMARCC1 YTHDC2 SSRP1 ARID1A MIDEAS HNRNPH1 PRRC2B | 1.48e-04 | 840 | 59 | 10 | int:WWP2 |
| Interaction | HNF4A interactions | 1.50e-04 | 275 | 59 | 6 | int:HNF4A | |
| Interaction | ARID1A interactions | 1.53e-04 | 276 | 59 | 6 | int:ARID1A | |
| Interaction | FMR1 interactions | 1.60e-04 | 536 | 59 | 8 | int:FMR1 | |
| Interaction | TEAD1 interactions | 1.64e-04 | 176 | 59 | 5 | int:TEAD1 | |
| Interaction | SOX17 interactions | 1.73e-04 | 95 | 59 | 4 | int:SOX17 | |
| Interaction | DPF1 interactions | 1.73e-04 | 95 | 59 | 4 | int:DPF1 | |
| Interaction | SOX9 interactions | 1.87e-04 | 97 | 59 | 4 | int:SOX9 | |
| Interaction | CELF1 interactions | 1.93e-04 | 288 | 59 | 6 | int:CELF1 | |
| Interaction | SMARCD2 interactions | 1.97e-04 | 183 | 59 | 5 | int:SMARCD2 | |
| Interaction | HNRNPUL2 interactions | 2.04e-04 | 291 | 59 | 6 | int:HNRNPUL2 | |
| Interaction | ATN1 interactions | 2.18e-04 | 187 | 59 | 5 | int:ATN1 | |
| Interaction | WWTR1 interactions | 2.24e-04 | 422 | 59 | 7 | int:WWTR1 | |
| Interaction | CIT interactions | MAGI1 GPRASP1 DNAH12 CELSR2 HGS SMARCC1 YTHDC2 TNKS1BP1 CHD4 SSRP1 RBM47 HNRNPH2 MAP3K4 | 2.34e-04 | 1450 | 59 | 13 | int:CIT |
| Interaction | RNF43 interactions | 2.41e-04 | 427 | 59 | 7 | int:RNF43 | |
| Interaction | TSG101 interactions | 2.54e-04 | 303 | 59 | 6 | int:TSG101 | |
| Interaction | HDGFL2 interactions | 2.58e-04 | 194 | 59 | 5 | int:HDGFL2 | |
| Interaction | FOXP3 interactions | 2.58e-04 | 432 | 59 | 7 | int:FOXP3 | |
| Interaction | KLF5 interactions | 2.64e-04 | 195 | 59 | 5 | int:KLF5 | |
| Interaction | SMARCAD1 interactions | 2.77e-04 | 197 | 59 | 5 | int:SMARCAD1 | |
| Interaction | ANKHD1-EIF4EBP3 interactions | 2.83e-04 | 108 | 59 | 4 | int:ANKHD1-EIF4EBP3 | |
| Interaction | SPG21 interactions | 2.90e-04 | 199 | 59 | 5 | int:SPG21 | |
| Interaction | YAP1 interactions | TFEB ARID1B ADSL SMARCC1 TNKS1BP1 CHD4 SSRP1 FOXA1 ARID1A MIDEAS HNRNPH1 | 2.93e-04 | 1095 | 59 | 11 | int:YAP1 |
| Interaction | YTHDF2 interactions | 2.97e-04 | 312 | 59 | 6 | int:YTHDF2 | |
| Interaction | MECP2 interactions | ZNF462 ARID1B SUGP1 SMARCC1 TNKS1BP1 SSBP2 CHD4 SSRP1 ARID1A CWC22 HNRNPH1 HNRNPH2 | 2.97e-04 | 1287 | 59 | 12 | int:MECP2 |
| Interaction | LOC102724159 interactions | 2.99e-04 | 9 | 59 | 2 | int:LOC102724159 | |
| Interaction | GMEB1 interactions | 3.10e-04 | 45 | 59 | 3 | int:GMEB1 | |
| Interaction | PDCD6 interactions | 3.25e-04 | 204 | 59 | 5 | int:PDCD6 | |
| Interaction | SIGLECL1 interactions | 3.36e-04 | 113 | 59 | 4 | int:SIGLECL1 | |
| Interaction | TBR1 interactions | 3.36e-04 | 113 | 59 | 4 | int:TBR1 | |
| Interaction | BCL7C interactions | 3.60e-04 | 115 | 59 | 4 | int:BCL7C | |
| Interaction | RAD18 interactions | 3.63e-04 | 457 | 59 | 7 | int:RAD18 | |
| Interaction | IWS1 interactions | 3.72e-04 | 116 | 59 | 4 | int:IWS1 | |
| Interaction | PRELID3B interactions | 3.73e-04 | 10 | 59 | 2 | int:PRELID3B | |
| Interaction | BRD9 interactions | 3.84e-04 | 117 | 59 | 4 | int:BRD9 | |
| Interaction | NR4A1 interactions | 3.88e-04 | 212 | 59 | 5 | int:NR4A1 | |
| Interaction | ALKBH5 interactions | 4.24e-04 | 50 | 59 | 3 | int:ALKBH5 | |
| Interaction | ETS1 interactions | 4.36e-04 | 121 | 59 | 4 | int:ETS1 | |
| Interaction | EYA2 interactions | 4.36e-04 | 121 | 59 | 4 | int:EYA2 | |
| Cytoband | 4p16.1 | 7.95e-08 | 79 | 62 | 5 | 4p16.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | 1.31e-05 | 222 | 62 | 5 | chr4p16 | |
| Cytoband | 2q31.3 | 1.39e-04 | 13 | 62 | 2 | 2q31.3 | |
| GeneFamily | SEC14 family|PRELI domain containing | 7.12e-05 | 6 | 40 | 2 | 1295 | |
| GeneFamily | AT-rich interaction domain containing | 4.92e-04 | 15 | 40 | 2 | 418 | |
| GeneFamily | RNA binding motif containing | 1.23e-03 | 213 | 40 | 4 | 725 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.28e-03 | 24 | 40 | 2 | 654 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.39e-03 | 25 | 40 | 2 | 775 | |
| GeneFamily | Collagens | 4.64e-03 | 46 | 40 | 2 | 490 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.12e-03 | 53 | 40 | 2 | 532 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.75e-06 | 177 | 59 | 5 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.32e-06 | 197 | 59 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.64e-06 | 199 | 59 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-05 | 125 | 59 | 4 | 43aa4b77dccf0ea2979218826af16034f2017c3a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.59e-05 | 157 | 59 | 4 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.59e-05 | 157 | 59 | 4 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.94e-05 | 166 | 59 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 7.97e-05 | 172 | 59 | 4 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.33e-05 | 174 | 59 | 4 | 40bb87d219aafab0357ab0d797efd38085fc0312 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.52e-05 | 175 | 59 | 4 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.91e-05 | 182 | 59 | 4 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.91e-05 | 182 | 59 | 4 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 183 | 59 | 4 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 184 | 59 | 4 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-04 | 185 | 59 | 4 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | f23f21781a758541f59c06efa7739d26a03fb478 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | 0de87109da9324c597fadf2eb782f0f158afe832 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 188 | 59 | 4 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.15e-04 | 189 | 59 | 4 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 189 | 59 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.15e-04 | 189 | 59 | 4 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 193 | 59 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 193 | 59 | 4 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-04 | 194 | 59 | 4 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-04 | 196 | 59 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.32e-04 | 196 | 59 | 4 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.32e-04 | 196 | 59 | 4 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Caecum-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 1.34e-04 | 197 | 59 | 4 | 40c8ff067e8242e2ca083ea04cd6026168191a97 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.40e-04 | 199 | 59 | 4 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-04 | 200 | 59 | 4 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-04 | 200 | 59 | 4 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-04 | 200 | 59 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-04 | 200 | 59 | 4 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | lymphoid-T_cell-pro-T_cell|World / Lineage, cell class and subclass | 1.64e-04 | 80 | 59 | 3 | 9bd3ad5029eb84efcdbf08fe268c29fa9b0b302b | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 7.71e-06 | 189 | 57 | 6 | 5248_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 8.19e-06 | 191 | 57 | 6 | 4647_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 8.96e-06 | 194 | 57 | 6 | 4319_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 9.50e-06 | 196 | 57 | 6 | 4728_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.04e-05 | 199 | 57 | 6 | 7367_UP | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.22e-04 | 193 | 57 | 5 | 6749_DN | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.22e-04 | 193 | 57 | 5 | 4951_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.22e-04 | 193 | 57 | 5 | 3906_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.22e-04 | 193 | 57 | 5 | 2721_DN | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.25e-04 | 194 | 57 | 5 | 4264_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 194 | 57 | 5 | 4126_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.28e-04 | 195 | 57 | 5 | 3559_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.28e-04 | 195 | 57 | 5 | 4994_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.28e-04 | 195 | 57 | 5 | 3721_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.28e-04 | 195 | 57 | 5 | 6299_UP | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.28e-04 | 195 | 57 | 5 | 2087_UP | |
| Drug | DO 897/99; Up 200; 8.2uM; HL60; HG-U133A | 1.31e-04 | 196 | 57 | 5 | 1728_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.31e-04 | 196 | 57 | 5 | 1021_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.31e-04 | 196 | 57 | 5 | 4591_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.31e-04 | 196 | 57 | 5 | 5338_UP | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.31e-04 | 196 | 57 | 5 | 5060_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.31e-04 | 196 | 57 | 5 | 2438_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 57 | 5 | 5292_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.34e-04 | 197 | 57 | 5 | 4557_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; PC3; HT_HG-U133A | 1.34e-04 | 197 | 57 | 5 | 2074_UP | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 57 | 5 | 6009_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.34e-04 | 197 | 57 | 5 | 3629_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A | 1.34e-04 | 197 | 57 | 5 | 2034_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.34e-04 | 197 | 57 | 5 | 5099_UP | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A | 1.34e-04 | 197 | 57 | 5 | 5840_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.37e-04 | 198 | 57 | 5 | 1506_DN | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.37e-04 | 198 | 57 | 5 | 4636_DN | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.37e-04 | 198 | 57 | 5 | 4788_DN | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.37e-04 | 198 | 57 | 5 | 6481_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.37e-04 | 198 | 57 | 5 | 2256_DN | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 1.40e-04 | 199 | 57 | 5 | 2693_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.40e-04 | 199 | 57 | 5 | 2933_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.40e-04 | 199 | 57 | 5 | 6321_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.44e-04 | 200 | 57 | 5 | 2919_UP | |
| Drug | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 1.65e-04 | 807 | 57 | 9 | ctd:C548651 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 3.17e-08 | 46 | 58 | 5 | DOID:5426 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.51e-07 | 69 | 58 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | Endometrial Neoplasms | 5.27e-06 | 58 | 58 | 4 | C0014170 | |
| Disease | Ptosis | 1.14e-05 | 3 | 58 | 2 | C0033377 | |
| Disease | Blepharoptosis | 1.14e-05 | 3 | 58 | 2 | C0005745 | |
| Disease | Endometrial Carcinoma | 1.25e-05 | 72 | 58 | 4 | C0476089 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.78e-05 | 5 | 58 | 2 | C3281201 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.29e-05 | 41 | 58 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.29e-05 | 41 | 58 | 3 | C0858252 | |
| Disease | non-high density lipoprotein cholesterol measurement | 7.38e-05 | 713 | 58 | 8 | EFO_0005689 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 7.96e-05 | 224 | 58 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 1.06e-04 | 8 | 58 | 2 | DOID:14320 (implicated_via_orthology) | |
| Disease | Neuroblastoma | 1.10e-04 | 47 | 58 | 3 | C0027819 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 1.35e-04 | 9 | 58 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | serum albumin measurement | 1.57e-04 | 592 | 58 | 7 | EFO_0004535 | |
| Disease | neuroblastoma (is_implicated_in) | 1.69e-04 | 10 | 58 | 2 | DOID:769 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 1.78e-04 | 142 | 58 | 4 | DOID:10534 (is_marker_for) | |
| Disease | breast cancer (is_implicated_in) | 2.20e-04 | 150 | 58 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | 2.32e-04 | 1074 | 58 | 9 | C0006142 | |
| Disease | apolipoprotein A 1 measurement | 2.42e-04 | 848 | 58 | 8 | EFO_0004614 | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 2.47e-04 | 12 | 58 | 2 | DOID:4914 (is_marker_for) | |
| Disease | right ventricular stroke volume measurement | 2.47e-04 | 12 | 58 | 2 | EFO_0021817 | |
| Disease | triglycerides in medium LDL measurement | 2.51e-04 | 62 | 58 | 3 | EFO_0022322 | |
| Disease | colorectal cancer (is_marker_for) | 2.62e-04 | 157 | 58 | 4 | DOID:9256 (is_marker_for) | |
| Disease | cortical surface area measurement | TANC2 NCOA2 MAGI1 ARID1B ATXN2 SSBP2 COL22A1 FGFR2 PAX7 HNRNPH1 | 2.65e-04 | 1345 | 58 | 10 | EFO_0010736 |
| Disease | triglycerides in small LDL measurement | 2.89e-04 | 65 | 58 | 3 | EFO_0022323 | |
| Disease | Coffin-Siris syndrome | 2.92e-04 | 13 | 58 | 2 | C0265338 | |
| Disease | apolipoprotein B measurement | 3.12e-04 | 663 | 58 | 7 | EFO_0004615 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.15e-04 | 301 | 58 | 5 | DOID:684 (is_marker_for) | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 3.75e-04 | 71 | 58 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | stomach cancer (is_implicated_in) | 3.90e-04 | 72 | 58 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 4.48e-04 | 16 | 58 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 5.69e-04 | 18 | 58 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | Breast Carcinoma | 6.48e-04 | 538 | 58 | 6 | C0678222 | |
| Disease | liver fibrosis measurement | 6.57e-04 | 86 | 58 | 3 | EFO_0010576 | |
| Disease | Craniosynostosis | 7.05e-04 | 20 | 58 | 2 | C0010278 | |
| Disease | testosterone measurement | 8.06e-04 | 1275 | 58 | 9 | EFO_0004908 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 8.55e-04 | 215 | 58 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | portal hypertension (biomarker_via_orthology) | 8.55e-04 | 22 | 58 | 2 | DOID:10762 (biomarker_via_orthology) | |
| Disease | progranulin measurement | 8.55e-04 | 22 | 58 | 2 | EFO_0004625 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 9.31e-04 | 220 | 58 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | Ovarian Serous Adenocarcinoma | 9.36e-04 | 23 | 58 | 2 | C1335177 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 9.89e-04 | 99 | 58 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.01e-03 | 225 | 58 | 4 | EFO_0008317, EFO_0010351 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.02e-03 | 24 | 58 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.02e-03 | 24 | 58 | 2 | C3805278 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.08e-03 | 102 | 58 | 3 | EFO_0004329, EFO_0004611 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.08e-03 | 229 | 58 | 4 | EFO_0004639, EFO_0008317 | |
| Disease | Kallmann Syndrome | 1.20e-03 | 26 | 58 | 2 | C0162809 | |
| Disease | Cholangiocarcinoma | 1.20e-03 | 26 | 58 | 2 | C0206698 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 1.24e-03 | 107 | 58 | 3 | EFO_0004614, EFO_0004615 | |
| Disease | remnant cholesterol measurement | 1.27e-03 | 108 | 58 | 3 | EFO_0010815 | |
| Disease | eye measurement | 1.29e-03 | 27 | 58 | 2 | EFO_0004731 | |
| Disease | Prostatic Neoplasms | 1.30e-03 | 616 | 58 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.30e-03 | 616 | 58 | 6 | C0376358 | |
| Disease | coronary artery disease, factor VII measurement | 1.38e-03 | 111 | 58 | 3 | EFO_0001645, EFO_0004619 | |
| Disease | right ventricular diastolic volume measurement | 1.39e-03 | 28 | 58 | 2 | EFO_0021814 | |
| Disease | lipoprotein A measurement | 1.41e-03 | 112 | 58 | 3 | EFO_0006925 | |
| Disease | Bilateral Wilms Tumor | 1.49e-03 | 29 | 58 | 2 | C2930471 | |
| Disease | longevity, healthspan, parental longevity | 1.49e-03 | 29 | 58 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | factor XI measurement, coronary artery disease | 1.52e-03 | 115 | 58 | 3 | EFO_0001645, EFO_0004694 | |
| Disease | Carcinoma, Granular Cell | 1.56e-03 | 116 | 58 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.56e-03 | 116 | 58 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.56e-03 | 116 | 58 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.56e-03 | 116 | 58 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.56e-03 | 116 | 58 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.56e-03 | 116 | 58 | 3 | C0001418 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.64e-03 | 118 | 58 | 3 | EFO_0001645, EFO_0004629 | |
| Disease | cholesteryl ester measurement | 1.65e-03 | 257 | 58 | 4 | EFO_0010351 | |
| Disease | cancer (implicated_via_orthology) | 1.92e-03 | 268 | 58 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 1.93e-03 | 33 | 58 | 2 | DOID:10283 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GINPAMYQSPMRLRS | 436 | P41595 | |
| MNPQIRNPMKAMYPG | 1 | Q9NRW3 | |
| NMAYGVKRLMSGPVP | 256 | P26378 | |
| MKRPQLYGMGSNPHS | 606 | Q8NFD5 | |
| AYAVDKGMPPARTPM | 891 | Q9HCU4 | |
| AQYSMFPAAPAPKMI | 451 | A0AV96 | |
| MAMASPAIGQRPYPL | 1 | Q8WWW0 | |
| GTVPRMMRPAPGQNY | 6 | P23759 | |
| MMRPAPGQNYPRTGF | 11 | P23759 | |
| SSPMDQMGKMRPQPY | 381 | O14497 | |
| QMGKMRPQPYGGTNP | 386 | O14497 | |
| KRNSMTPNPGYQPSM | 1201 | O14497 | |
| QPNLMPSNPDSGMYS | 1306 | O14497 | |
| KFRCPAGGNPMPTMR | 176 | P21802 | |
| MYENRPMSPSPASGL | 801 | Q96QZ7 | |
| YSPVIQGNARMMAPP | 1066 | Q99700 | |
| AYMDPMKQNGGPLTP | 1296 | Q9UPA5 | |
| GAYIPPAKLRMMQEQ | 131 | Q9HCG8 | |
| QVGMYKVHPPMPSSL | 861 | O95382 | |
| DPPRKLMAMQRPGPY | 196 | P55795 | |
| PPSMSSVMKNNPLYG | 81 | P59773 | |
| LAMYPNLGKDMPPDL | 131 | Q8NA70 | |
| DMNMPALEKYGAQPP | 1961 | Q6ZR08 | |
| QEMLSMYRRPGQAPP | 246 | Q9UJY4 | |
| DPPRKLMAMQRPGPY | 196 | P31943 | |
| NLSQYPMMRGPDPAA | 926 | P28290 | |
| MEMSGPYNSSPRPEQ | 591 | P29474 | |
| MRFLPMFLSDNPNPK | 996 | O15118 | |
| PCMSPMAYAPSNLGR | 136 | P55317 | |
| VMPSAPAIPGTNMYN | 1201 | Q9BYE9 | |
| YLPMQGNPPRRSKSA | 1096 | Q9HC77 | |
| LYSRAMGSMPLPPQG | 926 | Q9NX05 | |
| LPQYMKEIQPAPRMG | 86 | P27658 | |
| QMPPAYMKSSQGRPG | 1486 | Q8NFW1 | |
| GGPQLDRYVRPMMPQ | 171 | Q6PJG2 | |
| GMGRRQVMPPKYNFP | 111 | A0A1B0GVD1 | |
| RKAFLNAIMRYGMPP | 1421 | Q14839 | |
| MPGPPKNRQGDENYM | 1041 | Q9Y666 | |
| PDGIMAAYPATMLQP | 746 | Q05469 | |
| YGTSPPSTPRQMKRM | 81 | Q9Y6R4 | |
| FLENMIRMAPPYPNL | 1216 | Q5JY77 | |
| PMMPPGAQSYMNVAA | 311 | P41225 | |
| DNMYTLMNAVPPGPN | 266 | P81877 | |
| LGYINPEMQMPNTLP | 171 | P19484 | |
| AMQKYPNPMNPSVVG | 21 | Q9Y3B1 | |
| QIGSSAMPYKRNPMR | 286 | P30566 | |
| AMRKYPNPMNPSVLG | 21 | Q96N28 | |
| LSKMAQRPYQMPQLP | 1581 | Q9HCD6 | |
| HPAMYNPVFPMNNRP | 406 | Q14563 | |
| MNGMKPPLSGYRAAQ | 556 | Q68D10 | |
| NYQVDPESRPMAMGP | 536 | Q92922 | |
| GKDPNAPKRPMSAYM | 541 | Q08945 | |
| RNSSPYSVIPQPGMM | 906 | Q15596 | |
| MMLAYRFRPNPLNNP | 626 | Q8IWZ8 | |
| NLGMNSVPSRKMPYK | 121 | Q9HCZ1 | |
| PSARKMNMLAGPQPY | 76 | Q9C0C2 | |
| MRAQMPAFPLPYAQL | 556 | O14964 | |
| LDMQPYMSQPNTGPL | 301 | A8MUK1 | |
| LDMQPYMSQPNTGPL | 301 | D6R901 | |
| PYSAFPGMQPLEMVK | 2021 | Q5JSZ5 | |
| LEMVKPQSGSPYQPM | 2031 | Q5JSZ5 | |
| RSMQVYPMPQDFVPG | 151 | A0A0J9YWL9 | |
| LDMQPYMSQPNTGPL | 301 | C9JPN9 | |
| SPRPNMPVRYFIMKS | 1281 | Q9H6S0 | |
| LDMQPYMSQPNTGPL | 301 | Q0WX57 | |
| QPMYAMPGLASFLTP | 326 | Q96NM4 | |
| MSYPQMKPKSPHNSG | 341 | Q96JM2 | |
| LDMQPYMSQPNTGPL | 301 | D6RJB6 |